| The transferrin receptor and the targeted delivery of therapeutic agents against cancer TR Daniels, E Bernabeu, JA Rodríguez, S Patel, M Kozman, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (3), 291-317, 2012 | 870 | 2012 |
| GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ... Nature 603 (7903), 934-941, 2022 | 408 | 2022 |
| CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ... Nature medicine 27 (8), 1419-1431, 2021 | 335 | 2021 |
| Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells SH Huang, Y Ren, AS Thomas, D Chan, S Mueller, AR Ward, S Patel, ... The Journal of clinical investigation 128 (2), 876-889, 2018 | 188 | 2018 |
| Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, ... Nature Medicine 28 (9), 1860-1871, 2022 | 95 | 2022 |
| BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo Y Ren, SH Huang, S Patel, WDC Alberto, D Magat, D Ahimovic, ... The Journal of clinical investigation 130 (5), 2542-2559, 2020 | 91 | 2020 |
| CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma JH Baird, MJ Frank, J Craig, S Patel, JY Spiegel, B Sahaf, JS Oak, ... Blood, The Journal of the American Society of Hematology 137 (17), 2321-2325, 2021 | 61 | 2021 |
| Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer S Patel, RA Burga, AB Powell, EA Chorvinsky, N Hoq, SE McCormack, ... Frontiers in oncology 9, 196, 2019 | 58 | 2019 |
| Phase I trial using CD19/CD22 bispecific CAR T cells in pediatric and adult acute lymphoblastic leukemia (ALL) LM Schultz, LS Muffly, JY Spiegel, S Ramakrishna, N Hossain, C Baggott, ... Blood 134, 744, 2019 | 50 | 2019 |
| Toward a rapid production of multivirus-specific T cells targeting BKV, adenovirus, CMV, and EBV from umbilical cord blood H Dave, M Luo, JW Blaney, S Patel, C Barese, CR Cruz, EJ Shpall, ... Molecular Therapy Methods & Clinical Development 5, 13-21, 2017 | 48 | 2017 |
| HIV-specific, ex vivo expanded T cell therapy: feasibility, safety, and efficacy in ART-suppressed HIV-infected individuals JA Sung, S Patel, ML Clohosey, L Roesch, T Tripic, JAD Kuruc, N Archin, ... Molecular Therapy 26 (10), 2496-2506, 2018 | 43 | 2018 |
| T-cell therapies for HIV: preclinical successes and current clinical strategies S Patel, RB Jones, DF Nixon, CM Bollard Cytotherapy 18 (8), 931-942, 2016 | 42 | 2016 |
| Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy RA Burga, S Patel, CM Bollard, CR Y Cruz, R Fernandes Nanomedicine 11 (14), 1759-1767, 2016 | 39 | 2016 |
| Functionally active HIV-specific T cells that target Gag and Nef can be expanded from virus-naïve donors and target a range of viral epitopes: implications for a cure strategy … S Patel, S Lam, CR Cruz, K Wright, C Cochran, RF Ambinder, CM Bollard Biology of blood and marrow transplantation 22 (3), 536-541, 2016 | 39 | 2016 |
| A new method for reactivating and expanding T cells specific for Rhizopus oryzae P Castillo, KE Wright, DP Kontoyiannis, T Walsh, S Patel, E Chorvinsky, ... Molecular Therapy-Methods & Clinical Development 9, 305-312, 2018 | 31 | 2018 |
| Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells JA Rodríguez, R Luria-Pérez, HE López-Valdés, D Casero, TR Daniels, ... Leukemia & lymphoma 52 (11), 2169-2178, 2011 | 24 | 2011 |
| HIV-specific T cells generated from naive T cells suppress HIV in vitro and recognize wide epitope breadths S Patel, E Chorvinsky, S Albihani, CR Cruz, RB Jones, EJ Shpall, ... Molecular Therapy 26 (6), 1435-1446, 2018 | 19 | 2018 |
| HIV-specific T cells can be generated against non-escaped T cell epitopes with a GMP-compliant manufacturing platform S Patel, R Hanajiri, M Grant, D Saunders, S Van Pelt, M Keller, PJ Hanley, ... Molecular Therapy-Methods & Clinical Development 16, 11-20, 2020 | 17 | 2020 |
| A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies CD McCann, CH van Dorp, A Danesh, AR Ward, TR Dilling, TM Mota, ... Journal of Experimental Medicine 218 (7), e20201908, 2021 | 14 | 2021 |
| HLA-haplotype loss after TCRαβ/CD19-depleted haploidentical HSCT DC Shyr, BM Zhang, G Saini, ND Madani, LM Schultz, S Patel, ... Bone Marrow Transplantation 56 (3), 733-737, 2021 | 10 | 2021 |
